反应停对胆囊癌细胞影响的蛋白质组学研究
作者:
通讯作者:
作者单位:

作者简介:

朱国民 E-mail:zgm1976@yahoo.com.cn

基金项目:


Proteomics research of gallblader cancer cell line treatment with thalidomide
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的:筛选反应停作用于胆囊癌细胞后的相关差异蛋白,探讨反应停对胆囊癌细胞的作用机制。
    方法:应用蛋白质组学技术分离出胆囊癌细胞的差异蛋白,细胞分为实验组和对照组,对两组差异蛋白进行分析和鉴定。
    结果:共发现36个差异在2倍以上的蛋白点(P<0.05)。实验组中13个表达下调,23个上调。选择其中差异在3倍以上的10个蛋白质斑点作为差异表达的质谱分析,鉴定出7个蛋白质点。
    结论:反应停对胆囊癌细胞有一定作用。通过差异蛋白质点进一步探索其对胆囊癌的作用点,可为研究反应停的抗胆囊癌的作用机制提供线索。

    Abstract:

    Objective:To study the relevant differential expression proteins of GBC-SD cell line after treatment with thalidomide and the molecular mechanism.
    Methods:Proteomic techniques and methods were used to separate the  differential expression proteins in GBC-SD cells after treated wiht that idomide (experiment group) and control group.
    Results:The  differential expression proteins in experiment group and control group, whose spots variance was over 2-fold, were analysed  with PDQuest software,and found out 36 protein spots at difference level of expression(P<0.05), including 13 spots decreasing and 23 spots increasing  in experiment group. Then, 10 spots with more than 3-fold difference of  expression level were selected for anslysis, and 7 protein spots were identified.
    Conclusions:Thalidomide has some effect on GBC-SD cells. Study on the function of differential protein can be as a basis for research on the mechanism of thalidomide treatment of gallbladder cancer.

    参考文献
    相似文献
    引证文献
引用本文

朱国民|钟德玝|李学明|刘细平.反应停对胆囊癌细胞影响的蛋白质组学研究[J].中国普通外科杂志,2011,20(2):159-162.
DOI:10.7659/j. issn.1005-6947.2011.02.013

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2010-10-21
  • 最后修改日期:2011-01-22
  • 录用日期:
  • 在线发布日期: 2011-02-15